Press Announcements > FDA clears common blood cell count test that offers faster results for patients and providers
FDA clears common blood cell count test that offers faster results for patients and providers
The U.S. Food and Drug Administration today cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more health care settings, including physicians’ offices, clinics or other types of health care facilities, by a wider range of personnel (e.g. support staff). This broadened test access will allow for faster availability of results. Continue reading.